Edge Capital Group’s Abiomed Inc ABMD Stock Holding History

Edge Capital Group’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-12,008	Closed	-$2.95M	–	415
2022 Q3	$2.95M	Hold	12,008	–	–	0.24%	82
2022 Q2	$2.97M	Buy	12,008 +3	+0%	+$810	0.26%	81
2022 Q1	$3.98M	Hold	12,005	–	–	0.27%	79
2021 Q4	$4.31M	Hold	12,005	–	–	0.31%	71
2021 Q3	$3.91M	Hold	12,005	–	–	0.31%	67
2021 Q2	$3.75M	Hold	12,005	–	–	0.3%	69
2021 Q1	$3.83M	Hold	12,005	–	–	0.32%	69
2020 Q4	$3.89M	Hold	12,005	–	–	0.33%	68
2020 Q3	$3.33M	Hold	12,005	–	–	0.33%	64
2020 Q2	$2.9M	Hold	12,005	–	–	0.3%	71
2020 Q1	$1.74M	Buy	12,005 +5	+0%	+$830	0.21%	84
2019 Q4	$2.05M	Hold	12,000	–	–	0.2%	87
2019 Q3	$2.13M	Hold	12,000	–	–	0.22%	83
2019 Q2	$3.13M	Hold	12,000	–	–	0.3%	70
2019 Q1	$3.43M	Buy	+12,000	New	+$3.99M	0.34%	65

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Edge Capital Group's ABMD Position: Q4 2022 in Review

Edge Capital Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 12,008 shares — an estimated $2.95M sold.

Edge Capital Group first reported a position in ABMD in Q1 2019 and held it in 15 quarters. The position peaked at $4.31M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Edge Capital Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Edge Capital Group sold 12,008 Abiomed Inc shares in Q4 2022, an estimated $2.95M.
Edge Capital Group first reported a position in Abiomed Inc in Q1 2019 and held it in 15 quarters.
Edge Capital Group's Abiomed Inc position peaked at $4.31M in Q4 2021.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Edge Capital Group's 13F filing for Q4 2022, filed 7 Feb 2023.